Advisory Committee on the Medical Uses of Isotopes: Reschedule of Public Meeting, 36588 [2021-14709]
Download as PDF
<![CDATA[
36588
Federal Register / Vol. 86, No. 130 / Monday, July 12, 2021 / Notices
Commissioners’ Conference
Room, 11555 Rockville Pike, Rockville,
Maryland.
STATUS: Public.
MATTERS TO BE CONSIDERED:
PLACE:
For the Nuclear Regulatory Commission.
Wesley W. Held,
Policy Coordinator, Office of the Secretary.
[FR Doc. 2021–14784 Filed 7–8–21; 11:15 am]
BILLING CODE 7590–01–P
Week of July 12, 2021
There are no meetings scheduled for
the week of July 12, 2021.
NUCLEAR REGULATORY
COMMISSION
Week of July 19, 2021—Tentative
Advisory Committee on the Medical
Uses of Isotopes: Reschedule of
Public Meeting
There are no meetings scheduled for
the week of July 19, 2021.
There are no meetings scheduled for
the week of July 26, 2021.
There are no meetings scheduled for
the week of August 2, 2021.
Week of August 9, 2021—Tentative
There are no meetings scheduled for
the week of August 9, 2021.
Week of August 16, 2021—Tentative
There are no meetings scheduled for
the week of August 16, 2021.
khammond on DSKJM1Z7X2PROD with NOTICES
CONTACT PERSON FOR MORE INFORMATION:
For more information or to verify the
status of meetings, contact Wesley Held
at 301–287–3591 or via email at
Wesley.Held@nrc.gov. The schedule for
Commission meetings is subject to
change on short notice.
The NRC Commission Meeting
Schedule can be found on the internet
at: https://www.nrc.gov/public-involve/
public-meetings/schedule.html.
The NRC provides reasonable
accommodation to individuals with
disabilities where appropriate. If you
need a reasonable accommodation to
participate in these public meetings or
need this meeting notice or the
transcript or other information from the
public meetings in another format (e.g.,
braille, large print), please notify Anne
Silk, NRC Disability Program Specialist,
at 301–287–0745, by videophone at
240–428–3217, or by email at
Anne.Silk@nrc.gov. Determinations on
requests for reasonable accommodation
will be made on a case-by-case basis.
Members of the public may request to
receive this information electronically.
If you would like to be added to the
distribution, please contact the Nuclear
Regulatory Commission, Office of the
Secretary, Washington, DC 20555, at
301–415–1969, or by email at
Wendy.Moore@nrc.gov or Tyesha.Bush@
nrc.gov.
The NRC is holding the meetings
under the authority of the Government
in the Sunshine Act, 5 U.S.C. 552b.
VerDate Sep<11>2014
17:26 Jul 09, 2021
Jkt 253001
The U.S. Nuclear Regulatory
Commission (NRC) has rescheduled the
public teleconference meeting of the
Advisory Committee on the Medical
Uses of Isotopes (ACMUI) previously
scheduled for July 15, 2021. The
meeting notice, published in the
Federal Register on June 17, 2021 (86
FR 32285), is being reissued to inform
public stakeholders that the ACMUI
meeting will now be held on September
2, 2021. The meeting agenda and any
updates are available at https://
www.nrc.gov/reading-rm/doccollections/acmui/meetings/2021.html
or by emailing Ms. Kellee Jamerson at
the contact information below. The
agenda is subject to change.
DATES: The rescheduled teleconference
meeting will now be held on Thursday,
September 2, 2021, 1:00 p.m. to 3:00
p.m. Eastern Daylight Time.
SUMMARY:
Week of August 2, 2021—Tentative
Dated: July 7, 2021.
Nuclear Regulatory
Commission.
ACTION: Reschedule of public meeting.
AGENCY:
Week of July 26, 2021—Tentative
Date
September 2,
2021.
Webinar information
Link: https://
usnrc.webex.com.
Event number: 199 085
4780.
Conduct of the Meeting
The ACMUI Chair, Darlene F. Metter,
M.D., will preside over the meeting. Dr.
Metter will conduct the meeting in a
manner that will facilitate the orderly
conduct of business. The following
procedures apply to public participation
in the meeting:
1. Persons who wish to provide a
written statement should submit an
electronic copy to Ms. Jamerson at the
contact information listed above. All
written statements must be received by
August 30, 2021, three business days
prior to the meeting, and must pertain
to the topics on the agenda for the
meeting.
2. Questions and comments from
members of the public will be permitted
during the meeting, at the discretion of
the ACMUI Chairman.
3. The draft transcript and meeting
summary will be available on ACMUI’s
website https://www.nrc.gov/readingrm/doc-collections/acmui/meetings/
2021.html on or about November 1,
2021.
4. Persons who require special
services, such as those for the hearing
impaired, should notify Ms. Jamerson of
their planned participation.
This meeting will be held in
accordance with the Atomic Energy Act
of 1954, as amended (primarily Section
161a); the Federal Advisory Committee
Act (5 U.S.C. App); and the
Commission’s regulations in 10 CFR
part 7.
Dated at Rockville, Maryland this 7th day
of July, 2021.
For the U.S. Nuclear Regulatory
Commission.
Russell E. Chazell,
Federal Advisory Committee Management
Officer.
[FR Doc. 2021–14709 Filed 7–9–21; 8:45 am]
Public Participation: The meeting will
also be held as a webinar. Any member
of the public who wishes to participate
in any portion of this meeting should
register in advance of the meeting by
accessing the provided link and event
number above. Upon successful
registration, an email confirmation will
be generated providing the telephone
bridge line and a link to join the
webinar on the day of the meeting.
Members of the public should also
monitor the NRC’s Public Meeting
Schedule at https://www.nrc.gov/pmns/
mtg for any meeting updates. If there are
any questions regarding the meeting,
please contact Ms. Jamerson using the
information below.
FOR FURTHER INFORMATION CONTACT:
Kellee Jamerson, email:
Kellee.Jamerson@nrc.gov, telephone:
301–415–7408.
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
BILLING CODE 7590–01–P
OFFICE OF PERSONNEL
MANAGEMENT
Submission for Review: Life Insurance
Election, Standard Form (SF) 2817
Office of Personnel
Management.
ACTION: 30-Day notice and request for
comments.
AGENCY:
The Federal Employee
Insurance Operations (FEIO), Healthcare
& Insurance, Office of Personnel
Management (OPM) offers the general
public and other federal agencies the
opportunity to comment on an expiring
information collection request (ICR)
with minor edits, SF 2817—Life
Insurance Election.
SUMMARY:
E:\FR\FM\12JYN1.SGM
12JYN1
]]>Agencies
[Federal Register Volume 86, Number 130 (Monday, July 12, 2021)]
[Notices]
[Page 36588]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-14709]
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
Advisory Committee on the Medical Uses of Isotopes: Reschedule of
Public Meeting
AGENCY: Nuclear Regulatory Commission.
ACTION: Reschedule of public meeting.
-----------------------------------------------------------------------
SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) has rescheduled
the public teleconference meeting of the Advisory Committee on the
Medical Uses of Isotopes (ACMUI) previously scheduled for July 15,
2021. The meeting notice, published in the Federal Register on June 17,
2021 (86 FR 32285), is being reissued to inform public stakeholders
that the ACMUI meeting will now be held on September 2, 2021. The
meeting agenda and any updates are available at https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2021.html or by emailing Ms.
Kellee Jamerson at the contact information below. The agenda is subject
to change.
DATES: The rescheduled teleconference meeting will now be held on
Thursday, September 2, 2021, 1:00 p.m. to 3:00 p.m. Eastern Daylight
Time.
------------------------------------------------------------------------
Date Webinar information
------------------------------------------------------------------------
September 2, 2021..................... Link: https://usnrc.webex.com.
Event number: 199 085 4780.
------------------------------------------------------------------------
Public Participation: The meeting will also be held as a webinar.
Any member of the public who wishes to participate in any portion of
this meeting should register in advance of the meeting by accessing the
provided link and event number above. Upon successful registration, an
email confirmation will be generated providing the telephone bridge
line and a link to join the webinar on the day of the meeting. Members
of the public should also monitor the NRC's Public Meeting Schedule at
https://www.nrc.gov/pmns/mtg for any meeting updates. If there are any
questions regarding the meeting, please contact Ms. Jamerson using the
information below.
FOR FURTHER INFORMATION CONTACT: Kellee Jamerson, email:
[email protected], telephone: 301-415-7408.
Conduct of the Meeting
The ACMUI Chair, Darlene F. Metter, M.D., will preside over the
meeting. Dr. Metter will conduct the meeting in a manner that will
facilitate the orderly conduct of business. The following procedures
apply to public participation in the meeting:
1. Persons who wish to provide a written statement should submit an
electronic copy to Ms. Jamerson at the contact information listed
above. All written statements must be received by August 30, 2021,
three business days prior to the meeting, and must pertain to the
topics on the agenda for the meeting.
2. Questions and comments from members of the public will be
permitted during the meeting, at the discretion of the ACMUI Chairman.
3. The draft transcript and meeting summary will be available on
ACMUI's website https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2021.html on or about November 1, 2021.
4. Persons who require special services, such as those for the
hearing impaired, should notify Ms. Jamerson of their planned
participation.
This meeting will be held in accordance with the Atomic Energy Act
of 1954, as amended (primarily Section 161a); the Federal Advisory
Committee Act (5 U.S.C. App); and the Commission's regulations in 10
CFR part 7.
Dated at Rockville, Maryland this 7th day of July, 2021.
For the U.S. Nuclear Regulatory Commission.
Russell E. Chazell,
Federal Advisory Committee Management Officer.
[FR Doc. 2021-14709 Filed 7-9-21; 8:45 am]
BILLING CODE 7590-01-P
